New Risk • Jun 11
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). High level of non-cash earnings (28% accrual ratio). Market cap is less than US$10m (₹864.7m market cap, or US$9.03m). Reported Earnings • May 31
Full year 2026 earnings released: EPS: ₹7.80 (vs ₹11.38 in FY 2025) Full year 2026 results: EPS: ₹7.80 (down from ₹11.38 in FY 2025). Revenue: ₹706.3m (down 11% from FY 2025). Net income: ₹82.5m (down 33% from FY 2025). Profit margin: 12% (down from 16% in FY 2025). The decrease in margin was driven by lower revenue. Duyuru • May 22
Deepak Chemtex Limited to Report Second Half, 2026 Results on May 29, 2026 Deepak Chemtex Limited announced that they will report second half, 2026 results on May 29, 2026 New Risk • May 21
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹956.0m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹956.0m market cap, or US$9.92m). Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change). Valuation Update With 7 Day Price Move • Apr 11
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹92.80, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 20% over the past year. New Risk • Apr 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹869.0m market cap, or US$9.31m). Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change). Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₹71.20, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 35% over the past year. New Risk • Mar 16
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹903.3m (US$9.79m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹903.3m market cap, or US$9.79m). Valuation Update With 7 Day Price Move • Nov 17
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹113, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 13% over the past year. Duyuru • Nov 05
Deepak Chemtex Limited to Report First Half, 2026 Results on Nov 14, 2025 Deepak Chemtex Limited announced that they will report first half, 2026 results on Nov 14, 2025 Reported Earnings • Sep 04
Full year 2025 earnings released: EPS: ₹11.38 (vs ₹6.71 in FY 2024) Full year 2025 results: EPS: ₹11.38 (up from ₹6.71 in FY 2024). Revenue: ₹797.0m (up 60% from FY 2024). Net income: ₹123.6m (up 107% from FY 2024). Profit margin: 16% (up from 12% in FY 2024). The increase in margin was driven by higher revenue. Duyuru • Aug 26
Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025 Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025, at 15:00 Indian Standard Time. Valuation Update With 7 Day Price Move • Jul 29
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹162, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 68% over the past year. Duyuru • Jul 28
Deepak Chemtex Limited Announces Cessation of Directors with Effect from July 27, 2025 The Board of Directors of Deepak Chemtex Limited approved that Mr. Gautam Lath (DIN: 10198794) have completed his term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025 and Mrs. Pinki Kedia (DIN: 08455451) have completed her term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025. Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to ₹149, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 69% over the past year. New Risk • Jun 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (48% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.52b market cap, or US$17.8m). Reported Earnings • Jun 02
Full year 2025 earnings released: EPS: ₹11.69 (vs ₹6.71 in FY 2024) Full year 2025 results: EPS: ₹11.69 (up from ₹6.71 in FY 2024). Revenue: ₹819.5m (up 65% from FY 2024). Net income: ₹125.1m (up 109% from FY 2024). Profit margin: 15% (up from 12% in FY 2024). The increase in margin was driven by higher revenue. Duyuru • May 16
Deepak Chemtex Limited to Report Q4, 2025 Results on May 30, 2025 Deepak Chemtex Limited announced that they will report Q4, 2025 results on May 30, 2025 Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹101, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 1.7% over the past year. Valuation Update With 7 Day Price Move • Dec 24
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year. New Risk • Dec 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (64% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹1.78b market cap, or US$21.0m). Valuation Update With 7 Day Price Move • Dec 10
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to ₹164, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year. Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₹120, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 34x in the Chemicals industry in India. Duyuru • Nov 09
Deepak Chemtex Limited to Report First Half, 2025 Results on Nov 14, 2024 Deepak Chemtex Limited announced that they will report first half, 2025 results on Nov 14, 2024 Duyuru • Aug 30
Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024 Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024. Valuation Update With 7 Day Price Move • Jul 04
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹97.15, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 34x in the Chemicals industry in India. Reported Earnings • Jun 05
Full year 2024 earnings released: EPS: ₹6.73 (vs ₹7.90 in FY 2023) Full year 2024 results: EPS: ₹6.73 (down from ₹7.90 in FY 2023). Revenue: ₹505.4m (up 8.2% from FY 2023). Net income: ₹60.0m (down 5.0% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • May 21
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹105, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 30x in the Chemicals industry in India. Duyuru • May 17
Deepak Chemtex Limited to Report Second Half, 2024 Results on May 22, 2024 Deepak Chemtex Limited announced that they will report second half, 2024 results on May 22, 2024 Valuation Update With 7 Day Price Move • Apr 18
Investor sentiment improves as stock rises 32% After last week's 32% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.8x. Average trailing P/E is 30x in the Chemicals industry in India. New Risk • Apr 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 14% over the past year. High level of non-cash earnings (37% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹937.5m market cap, or US$11.2m). Valuation Update With 7 Day Price Move • Apr 02
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹81.00, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 29x in the Chemicals industry in India. Buying Opportunity • Dec 14
Now 22% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be ₹151, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last year. Earnings per share has grown by 49%. Board Change • Dec 06
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Pinki Kedia was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.